Congenital long QT syndrome (LQTS) is a cardiac channelopathy characterized by a prolongation of the QT interval and T-wave abnormalities, caused, in most cases, by mutations in KCNQ1, KCNH2, and SCN5A. Although the predominant pattern of LQTS inheritance is autosomal dominant, compound heterozygous mutations in genes encoding potassium channels have been reported, often with early disease onset and more severe phenotypes. Since the molecular mechanisms underlying severe phenotypes in carriers of compound heterozygous mutations are unknown, it is possible that these compound mutations lead to synergistic or additive alterations to channel structure and function. In this study, all-atom molecular dynamic simulations of KCNQ1 and hERG channels were carried out, including wild-type and channels with compound mutations found in two patients with severe LQTS phenotypes and limited family history of the disease. Because channels can likely incorporate different subunit combinations from different alleles, there are multiple possible configurations of ion channels in LQTS patients. This analysis allowed us to establish the structural impact of different configurations of mutant channels in the activated/open state. Our data suggest that channels with these mutations show moderate changes in folding energy (in most cases of stabilizing character) and changes in channel mobility and volume, differentiating them from each other and from WT. This would indicate possible alterations in K+ ion flow. Hetero-tetrameric mutant channels showed intermediate structural and volume alterations vis-à-vis homo-tetrameric channels. These findings support the hypothesis that hetero-tetrameric channels in patients with compound heterozygous mutations do not necessarily lead to synergistic structural alterations.
17 February 2026 in Journal of Interventional Cardiac Electrophysiology
Background and Objectives: Neonates with moderate-to-severe hypoxic–ischemic encephalopathy (HIE) in low- and middle-income countries (LMICs) remain at high risk of neurological sequelae despite access to therapeutic hypothermia (TH). Real-time accessible biomarkers are required to improve risk stratification and guide neuroprotective care in these settings. This study evaluated the predictive capacity of heart rate variability (HRV) metrics for brain injury detected using magnetic resonance imaging (MRI) in neonates with HIE who underwent TH at an LMIC. Materials and Methods: We conducted a prospective observational study of 87 neonates treated with TH in a tertiary neonatal intensive care unit in Colombia. HRV was recorded during the first 24 h of TH, during rewarming, and 24 h after rewarming. Brain MRI was performed within the first week of life and scored using the Rutherford system. Associations between HRV metrics and global and regional brain injuries were analyzed using receiver operating characteristic (ROC) curves and multivariable logistic regression models. Results: Low-frequency (LF) and high-frequency (HF) powers were significantly lower in neonates with MRI abnormalities. LF power during rewarming demonstrated the highest predictive accuracy (AUC = 0.90), followed by HF power during the first 24 h (AUC = 0.80). Region-specific analyses showed that LF power reduction was significantly associated with white matter and basal ganglia injury. Conclusions: HRV, particularly LF power during rewarming, is a promising and accessible biomarker for regional brain injury in neonates with perinatal asphyxia treated with TH.